CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Mouse Models as a Tool for Understanding Progression in BrafV600E-Driven Thyroid Cancers
Iñigo Landa, Jeffrey A. Knauf
Endocrinol Metab. 2019;34(1):11-22.   Published online February 15, 2019

Excel Download

BRAFV600E Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thyroid Cancer?
European Thyroid Journal. 2016;5(3):195-200   Crossref logo
Link1 Link2

Mouse Models as a Tool for Understanding Progression in BrafV600E-Driven Thyroid Cancers
Endocrinology and Metabolism. 2019;34(1):11   Crossref logo
Link1 Link2 Link3

Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation
Oncology Research and Treatment. 2017;40(10):586-592   Crossref logo

A multivariable model of BRAFV600E and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma

Cancer Management and Research. 2019;Volume 11:7211-7217   Crossref logo
Link1 Link2

Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report
OncoTargets and Therapy. 2019;Volume 12:443-447   Crossref logo
Link1 Link2

Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features

Cancer Management and Research. 2020;Volume 12:3371-3378   Crossref logo
Link1 Link2

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis
Cancer Management and Research. 2018;Volume 10:1005-1013   Crossref logo
Link1 Link2

Durable Clinical Response of Advanced Lung Adenocarcinoma Harboring EGFR-19del/T790M/BRAFV600E Mutations After Treating with Osimertinib and Dabrafenib Plus Trametinib: A Case Report

OncoTargets and Therapy. 2020;Volume 13:7933-7939   Crossref logo
Link1 Link2

Does BRAF V600E, BRAF-wt, or BRAF Pseudogene Expression Predict Aggressiveness of Papillary Thyroid Carcinoma?
Clinical Thyroidology. 2016;28(5):150-152   Crossref logo
Link1 Link2

Papillary thyroid carcinomas with and without BRAF  V600E mutations are morphologically distinct
Histopathology. 2012;60(7):1052-1059   Crossref logo
Link1 Link2